ALZAI Health Corp. Enters into MOU with Quanterix Corporation to Advance Early Alzheimer's Disease Identification
Toronto, Ontario--(Newsfile Corp. - November 13, 2026) - ALZAI Health Corp. (TSXV: ALZI) (OTCQB: ALZIF) (FSE: H2F) ("ALZAI" or the "Company"), a healthcare technology company developing artificial intelligence-driven disease risk identification solutions, is pleased to announce that it has entered into a Memorandum of Understanding ("MOU") with Quanterix Corporation ("Quanterix"), a leader in ultra-sensitive biomarker detection and blood-based diagnostic testing, to explore collaboration...